top of page

First AI Platform for Breast Cancer Risk Prediction Approved By FDA

Connie Lehman, MD

Jun 3, 2025

Connie Lehman, MD, Founder of Clairity, explains how the Class II software, as a medical device, can extend the runway for breast cancer treatment

bottom of page